Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Enovis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Enovis's operating cash flow for the twelve months ending Jul 3, 2026 was $270.10M, up 43.6% year over year. For fiscal 2025 it was $217.29M, up 91.4% from the year before. Over ten years it grew -3.3% a year on average. The highest annual figure on record is $385.76M in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $217.29M | +91.4% |
| FY2024 | Dec 31, 2024 | $113.50M | -15.9% |
| FY2023 | Dec 31, 2023 | $134.99M | – |
| FY2022 | Dec 31, 2022 | -$55.86M | -115.7% |
| FY2021 | Dec 31, 2021 | $356.10M | +17.9% |
| FY2020 | Dec 31, 2020 | $301.94M | +130.6% |
| FY2019 | Dec 31, 2019 | $130.95M | -42.2% |
| FY2018 | Dec 31, 2018 | $226.37M | +3.5% |
| FY2017 | Dec 31, 2017 | $218.77M | -11.4% |
| FY2016 | Dec 31, 2016 | $246.97M | -18.7% |
| FY2015 | Dec 31, 2015 | $303.81M | -21.2% |
| FY2014 | Dec 31, 2014 | $385.76M | +6.5% |
| FY2013 | Dec 31, 2013 | $362.17M | +108.1% |
| FY2012 | Dec 31, 2012 | $174.02M | +204.5% |
| FY2011 | Dec 31, 2011 | $57.15M | -7.8% |
| FY2010 | Dec 31, 2010 | $61.97M | +60.1% |
| FY2009 | Dec 31, 2009 | $38.70M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $75.03M | +57.1% |
| Q1 FY2026 | Apr 3, 2026 | $23.95M | – |
| Q4 FY2025 | Dec 31, 2025 | $88.54M | +0.2% |
| Q3 FY2025 | Oct 3, 2025 | $82.58M | +54.2% |
| Q2 FY2025 | Jul 4, 2025 | $47.77M | +514.6% |
| Q1 FY2025 | Apr 4, 2025 | -$1.60M | – |
| Q4 FY2024 | Dec 31, 2024 | $88.33M | +29.1% |
| Q3 FY2024 | Sep 27, 2024 | $53.56M | +72.7% |
| Q2 FY2024 | Jun 28, 2024 | $7.77M | -72.3% |
| Q1 FY2024 | Mar 29, 2024 | -$36.16M | -584.9% |
| Q4 FY2023 | Dec 31, 2023 | $68.42M | – |
| Q3 FY2023 | Sep 29, 2023 | $31.01M | +59.8% |
| Q2 FY2023 | Jun 30, 2023 | $28.10M | – |
| Q1 FY2023 | Mar 31, 2023 | $7.46M | – |
| Q4 FY2022 | Dec 31, 2022 | -$35.96M | -137.4% |
| Q3 FY2022 | Sep 30, 2022 | $19.41M | -80.0% |
| Q2 FY2022 | Jul 1, 2022 | -$24.89M | -131.8% |
| Q1 FY2022 | Apr 1, 2022 | -$14.42M | -117.1% |
| Q4 FY2021 | Dec 31, 2021 | $96.22M | -25.3% |
| Q3 FY2021 | Oct 1, 2021 | $97.13M | +21.5% |
| Q2 FY2021 | Jul 2, 2021 | $78.37M | +111.9% |
| Q1 FY2021 | Apr 2, 2021 | $84.38M | +50.1% |
| Q4 FY2020 | Dec 31, 2020 | $128.80M | +97.6% |
| Q3 FY2020 | Oct 2, 2020 | $79.92M | +44.5% |
| Q2 FY2020 | Jul 3, 2020 | $36.99M | -55.3% |
| Q1 FY2020 | Apr 3, 2020 | $56.23M | – |
| Q4 FY2019 | Dec 31, 2019 | $65.20M | -48.1% |
| Q3 FY2019 | Sep 27, 2019 | $55.32M | -17.6% |
| Q2 FY2019 | Jun 28, 2019 | $82.72M | +127.8% |
| Q1 FY2019 | Mar 29, 2019 | -$72.29M | – |
| Q4 FY2018 | Dec 31, 2018 | $125.56M | +20.6% |
| Q3 FY2018 | Sep 28, 2018 | $67.15M | +316.2% |
| Q2 FY2018 | Jun 29, 2018 | $36.32M | -37.5% |
| Q1 FY2018 | Mar 31, 2018 | -$2.66M | -106.6% |
| Q4 FY2017 | Dec 31, 2017 | $104.08M | -28.3% |
| Q3 FY2017 | Sep 29, 2017 | $16.13M | -64.5% |
| Q2 FY2017 | Jun 30, 2017 | $58.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $40.41M | – |
| Q4 FY2016 | Dec 31, 2016 | $145.12M | – |
| Q3 FY2016 | Sep 30, 2016 | $45.44M | – |
See a number that looks wrong?